Nalu Medical, Inc. ("Nalu"), a leader in peripheral nerve stimulation, announced the publication of a study in Pain ...

A Manitoba woman is suing St. Boniface Hospital and two staff after undergoing a medical procedure that she says left her ...

Physical therapy can be effective in treating a condition more than 3 million Americans live with every day: chronic pain.

Attributes of the drug, company and its clinical trials play a fundamental role in drug-specific PTSR and likelihood of approval. CFTX-1554 is under development for the treatment of peripheral ...

Pacira BioSciences PCRX announced that the FDA has cleared its application to market a new Smart Tip for the iovera system ...

Pacira launches a new iovera° Smart Tip for chronic back pain relief, offering an alternative to radiofrequency ablation with ...

Treatment with XG005 resulted in statistically significant and clinically meaningful reduction in post-surgical pain ...

Pacira BioSciences, Inc. (Nasdaq: PCRX), the industry leader in the delivery of innovative, non-opioid pain therapies to transform the lives of patients, announced today that it has received clearance ...

ANP-390 is under clinical development by AlphaNavi Pharma and currently in Phase I for Peripheral Neuropathic Pain.